Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impacts of Mechanistic Target of Rapamycin (mTOR) Inhibition on Aged Human Muscle.

NCT05414292 is registered in ClinicalTrials.gov with University of Nottingham as lead sponsor.

NCT NCT05414292
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05414292 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impacts of Mechanistic Target of Rapamycin (mTOR) Inhibition on Aged Human Muscle.
Lead sponsor
University of Nottingham
Phase
Not applicable
Overall status
Recruiting
Start date
August 6, 2021
Completion date
May 1, 2027
Enrollment
16 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

age-related sarcopenia, muscle atrophy